Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Neuropharmacology|November 1, 1990
Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathwaysS Izenwasser, L L Werling, J G Rosenberger, et al.
Journal of Neurochemistry|February 1, 1991
Nicotine indirectly inhibits [3H]dopamine uptake at concentrations that do not directly promote [3H]dopamine release in rat striatumS Izenwasser, H M Jacocks, J G Rosenberger, et al.
European Journal of Pharmacology|February 28, 2001
Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaineP Romualdi, C D'Addario, S Ferri, et al.
Brain Research. Molecular Brain Research|August 1, 1996
Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamenP Romualdi, A Donatini, S Izenwasser, et al.
Neuroscience|October 24, 2006
Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNSC D'Addario, M Di Benedetto, S Izenwasser, et al.
European Journal of Pharmacology|October 3, 1994
Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitorsS Izenwasser, P Terry, B Heller, et al.
Journal of Chemical Neuroanatomy|February 24, 2001
Serotonin transporters upregulate with chronic cocaine useD C Mash, J K Staley, S Izenwasser, et al.
Journal of Medicinal Chemistry|June 19, 1998
Synthesis and dopamine transporter affinity of the four stereoisomers of (+/-)-2-(methoxycarbonyl)-7-methyl-3-phenyl-7-azabicyclo[2.2.1]heptaneC Zhang, S Izenwasser, J L Katz, et al.
Synapse (New York, N.Y.)|September 1, 1993
Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activityE M Unterwald, B M Cox, M J Kreek, et al.
European Journal of Pharmacology|July 4, 1998
Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonistsS Izenwasser, D Thompson-Montgomery, S E Deben, et al.
Pageof 6